1、投稿方式：在线投稿。

2、官网网址：

http://www.keaipublishing.com/en/journals/journal-of-biosafety-and-biosecurity/

https://www.sciencedirect.com/journal/journal-of-biosafety-and-biosecurity

3、投稿网址：

https://www2.cloud.editorialmanager.com/jbb/default2.aspx

4、出刊日期：季刊，逢季末月出版。

2024年2月25日星期日

《生物安全和生物安保（英文）》期刊介绍

Journal of Biosafety and Biosecurity （《生物安全和生物安保》）主要发表包括研究论著、短篇报道、个案分析、专家评论、综述和编辑点评等有关生物安全和生物安保方面的文章，如病原体研究、生物安全和安保设施、设备设计、运转与管理；风险评估与应对措施；核心技术突破；政策研究等。

主编

徐建国：中国工程院院士、传染病预防控制国家重点实验室主任

袁志明：中国科学院武汉分院院长、武汉国家生物安全实验室主任

《生物安全和生物安保（英文）》作者指南

【官网信息】

Guide for Authors

INTRODUCTION

Types of paper

Contributions falling into the following categories will be considered for publication: Original research papers, reviews, letters to the editor.

Please ensure that you select the appropriate article type from the list of options when making your submission. Authors contributing to special issues should ensure that they select the special issue article type from this list.

BEFORE YOU BEGIN

Ethics in Publishing

For information on Ethics in Publishing and Ethical guidelines for journal publication see https://www.elsevier.com/publishingethics and https://www.elsevier.com/ethicalguidelines.

Animal experiments

Does your research involve experimentation on animals? If so, please provide name of the ethical committee approving these experiments and confirm authors' compliance with all relevant ethical regulations.

Human subjects

Does your study include human subjects? If so, please provide name of the ethical committee approving these experiments, confirm authors' compliance with all relevant ethical regulations, and confirm that written consent has been obtained from all patients.

Informed consent

If your manuscript is related to clinical study, please provide following pieces of information and state them in your manuscript: 1) date of IRB approval and the approval number, 2) status of informed consent (IC); [e.g. Was written IC required? Was your clinical study approved without IC? If so, the reason why?]

I confirm that I have obtained all consents required by applicable law for the publication of any personal details or images of patients, research subjects or other individuals that are used in the materials submitted to KeAi. I have retained a written copy of all such consents and I agree to provide KeAi with copies of the consents or evidence that such consents have been obtained if requested by KeAi.

Clinical research must include IRB approval and patient consent forms.

Conflict of interest

All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See also https://www.elsevier.com/conflictsofinterest.

Submission declaration

Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service CrossCheck, see https://www.elsevier.com/editors/perk/plagiarism-complaints/plagiarism-detection.

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.

Author contributions

For transparency, we encourage authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; Writing - review & editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following. More details and an example

Changes to authorship

This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:

Before the accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.

After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.

……

更多详情：

http://www.keaipublishing.com/en/journals/journal-of-biosafety-and-biosecurity/guide-for-authors/